On August 8, Orbis International launched its first on-site training program on board the Flying Eye Hospital, a fully accredited ophthalmic teaching hospital on board a plane, with assistance from Alcon.
HOYA Vision Care has entered into a strategic joint venture with Chinese eyeglass lens manufacturer Jiangsu Sigo Optical's (JSO) Founder and Chief Executive Officer Liu Jianzhong.
Clearside Biomedical announced it has entered into an agreement with HealthCare Royalty Partners in a deal worth up to $65 million.
Prevent Blindness has been recognized by the Office of Disease Prevention and Health Promotion (ODPHP) within the U.S. Department of Health and Human Services (HHS) as a Healthy People 2030 Champion.
Robin Kuriakose, MD, a fellow physician in cornea and refractive surgery at the Northwestern Memorial Hospital, has introduced SightKick. The new MacOS application is specifically designed to reduce digital eye strain.
The U.S. Food and Drug Administration (FDA) on July 28 released a draft guidance paper that included recommendations for the content and presentation of patient labeling information for LASIK device labels.
LumiThera Inc., a commercial stage medical device business that provides photobiomodulation (PBM) treatment for ocular disease and damage, announced that its wholly-owned subsidiary acquired the assets of MacuLogix.
Walmart and WALDO have partnered to increase the accessibility and affordability of eyecare. WALDO is an innovative and affordable eyecare brand that believes in the power of positive vision, and Walmart is the first retailer to exclusively retail its pro
EyeCare Partners (ECP) has entered into an agreement to partner with Commonwealth Eye Care Associates (CECA) and Retina Institute of Virginia (RIV). Financial terms of the agreement were not disclosed at the time of publication.
Oyster Point Pharma announced the expansion of patient access to its nasal spray medication for dry eye disease, Tyrvaya (varenicline solution), and provided an update In an update on Tyrvaya's US commercial success in the US.